RBI
TNYA icon

Raiffeisen Bank International’s Tenaya Therapeutics TNYA Stock Holding History

Raiffeisen Bank International’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$620K Buy
1,000,000
+100,000
+11% +$73.8K 0.01% 440
2025
Q4 		$630K Buy
900,000
+550,000
+157% +$748K 0.01% 414
2025
Q3 		$553K Buy
+350,000
New +$353K 0.01% 410

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raiffeisen Bank International's TNYA Position: Q1 2026 in Review

Raiffeisen Bank International increased its Tenaya Therapeutics (TNYA) stake by 11% in Q1 2026, buying an estimated $73.8K and bringing the position to 1,000,000 shares worth $620K. The position accounts for 0.01% of the portfolio, ranked #440.

Raiffeisen Bank International first reported a position in TNYA in Q3 2025 and has held it in 3 quarters since. The position peaked at $630K in Q4 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Raiffeisen Bank International held 1,000,000 shares of Tenaya Therapeutics worth $620K as of Q1 2026.
  • Raiffeisen Bank International bought 100,000 Tenaya Therapeutics shares in Q1 2026, an estimated $73.8K.
  • Tenaya Therapeutics made up 0.01% of Raiffeisen Bank International's portfolio in Q1 2026, its #440 holding.
  • Raiffeisen Bank International first reported a position in Tenaya Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Raiffeisen Bank International's Tenaya Therapeutics position peaked at $630K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.